Your browser doesn't support javascript.
loading
A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine.
Gutiérrez, Ramiro L; Porter, Chad K; Jarell, Abel; Alcala, Ashley; Riddle, Mark S; Turiansky, George W.
Afiliação
  • Gutiérrez RL; Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States. Electronic address: ramiro.l.gutierrez.mil@mail.mil.
  • Porter CK; Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States. Electronic address: chad.k.porter.civ@med.mail.mil.
  • Jarell A; Dermatology Department, Walter Reed National Military Medical Center, Bethesda, MD, United States.
  • Alcala A; Enteric Diseases Department, Naval Medical Research Center, Silver Spring, MD, United States.
  • Riddle MS; Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
  • Turiansky GW; Uniformed Services University of the Health Sciences, Bethesda, MD, United States. Electronic address: gwturiansky@verizon.net.
Vaccine ; 38(21): 3773-3779, 2020 05 06.
Article em En | MEDLINE | ID: mdl-32253098
ABSTRACT

BACKGROUND:

Trials assessing the safety of novel vaccine candidates are essential in the evaluation and development of candidate vaccines. Immunogenicity and dose-sparing features of vaccination approaches which target skin and associated tissues have garnered increased interest; for enteric vaccines, cutaneous vaccination has been of particular interest. Cutaneous vaccine site reactions are among the most common and visible vaccine related adverse events (AEs) when skin routes are used. Regulatory guidelines governing classification of severity focus on functional impact but are insufficient to characterize a spectrum of skin reaction and allow for comparisons of routes, doses and products with similar local cutaneous AEs.

OBJECTIVES:

Our group developed a grading scale to evaluate and compare cutaneous vaccine site reactions ahead of early-phase clinical trials of intradermal (ID) and transcutaneous immunization (TCI) with enterotoxigenic E.coli (ETEC) vaccine candidates (adhesin-based vaccine co-administered with LTR192G). We reviewed existing methods for characterizing the appearance and severity of local vaccine site reactions following TCI and ID vaccination and devised a standardized vaccine site appearance grading scale (VSAGS) for use in the clinical development of novel ETEC vaccine candidates which focused on pathophysiologic manifestation of skin findings.

RESULTS:

Available data from published reports revealed erythematous papules and pruritus were the most common local AEs associated with TCI. Frequency of reactions varied notably across studies as did TCI vaccination methodologies and products. ID vaccination commonly results in erythema and induration at the vaccine site as well as pigmentation changes. There was no published methodology to characterize the spectrum of dermatologic findings.

CONCLUSION:

ID and TCI vaccination are associated with a largely predictable range of cutaneous AEs. A grading scale focused on the appearance of cutaneous changes was useful in comparing cutaneous AEs. A standardized grading scale will facilitate documentation and comparison of cutaneous AEs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Vacinação / Vacinas contra Escherichia coli / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pele / Vacinação / Vacinas contra Escherichia coli / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article